Concepedia

Roberto Spreafico

RS

56

Publications

8.8K

Citations

40

H-Index

2004

Active since

Affiliations

University of California, Los Angeles(Current)

QB3

University of Milano-Bicocca

VIR Biotechnology (United States)

Vir Biotechnology (Switzerland)

Roberto Spreafico is an author at University of California, Los Angeles specializing in medicine, immunology, and covid-19.

ORCID

Top concepts

Publications per year

2004–2024

56

Publications

56

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto, Young‐Jun Park, Martina Beltramello et al. · Nature · 2020 · 2.1K citations · Full text

, , +2

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson, Laura E. Rosen, James G. Shepherd et al. · Cell · 2021 · 652 citations · Full text

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp et al. · Science · 2020 · 615 citations · Full text

, , +18

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

Ann M. Arvin, Katja Fink, Michael Schmid et al. · Nature · 2020 · 527 citations · Full text

Type III interferons disrupt the lung epithelial barrier upon viral recognition

Achille Broggi, Sreya Ghosh, Benedetta Sposito et al. · Science · 2020 · 407 citations · Full text

Rows per page

1–5 of 56